Monoclonal antibodies may neutralize many norovirus variants
Researchers have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract......»»
AMD is still getting shortchanged by laptop brands
HP has announced AMD variants of its new Envy x360 15 laptops. The problem? They don't come with all the same premium features as the Intel counterparts......»»
Vaccine-induced antibodies may be less effective against several new SARS-CoV-2 variants
Researchers find that neutralizing antibodies raised by COVID-19 vaccines are not as effective at neutralizing some new, circulating SARS-CoV-2 variants......»»
Serimmune launches new immune response mapping service for COVID-19
Immune intelligence startup Serimmune hopes to better understand the relationship between antibody epitopes (the parts of antigen molecules that bind to antibodies) and the SARS-CoV-2 virus. The company’s proprietary technology, originally develope.....»»
2020 Tesla Model S vs. 2020 Tesla Model 3
Upmarket variants of the Tesla Model 3 cost about as much as a second-hand Model S, but which one is better?.....»»
Study of coronavirus variants predicts virus evolving to escape current vaccines
A new study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2......»»
New evidence COVID-19 antibodies, vaccines less effective against variants
New research has found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic, potentially undermining the effectiveness of vaccines and antibody-based drugs.....»»
New method facilitates development of antibody-based drugs
In recent years, therapeutic antibodies have transformed the treatment of cancer and autoimmune diseases. Now, researchers have developed a new, efficient method based on the genetic scissors CRISPR-Cas9, that facilitates antibody development......»»
UK to fast-track modified COVID vaccines designed to combat new variants
Coronavirus vaccines that have been tweaked to deal with new variants of the disease will be fast-tracked for authorisation, the UK regulator has said......»»
Nanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies
Researchers have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models. According to a new study, the vaccine produced potent neutralizing antibodies among precli.....»»
New cell line could lead to more reliable vaccine development to fight costly pig virus
Vaccines are an important tool in fighting porcine reproductive and respiratory syndrome (PRRS), but the fast-mutating virus that causes the disease sometimes requires the production of autogenous vaccines tailored to particular variants......»»
Research team discovers plant variant that largely neutralizes arsenic
The agricultural cultivation of the staple food of rice harbors the risk of possible contamination with arsenic that can reach the grains following uptake by the roots. In their investigation of over 4,000 variants of rice, a Chinese-German research.....»»
Mutant gene-targeted immunotherapy approach developed
A novel targeted immunotherapy approach employs new antibodies against genetically altered proteins to target cancers......»»
This virus will keep evolving - and that makes international travel risky
There is an adage from the world of terrorism that equally applies to the emerging new variants of COVID-19......»»
A 3rd shot? A new booster? Vaccine makers race to trials to beat variants
Could a 3rd shot of current COVID vaccines be enough to thwart variants? Enlarge / COVID-19 vaccine at a vaccination center in Madrid on Feb. 26, 2021. (credit: Getty | NurPhoto) With worrisome coronavirus variants seemingly emerging and spre.....»»
How to neutralize the SARS-CoV-2 virus
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus. But not every type of antibody can neutralize the v.....»»
Antibodies recognize and attack different SARS-CoV-2 spike shapes
The spikes on the SARS-CoV-2 virus, which causes COVID-19, change shapes. New research reveals ways that antibodies can recognize these different shapes and block the virus and informs the design of vaccines and antiviral therapies......»»
People with SARS-CoV-2 antibodies may have low risk of future infection, study finds
People who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months, according to a new study. This finding may explain why.....»»
Researchers develop two new rapid COVID-19 diagnostic tests
University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19—one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms. The findings were rec.....»»
Vaccines Adapted for Variants Will Not Need Lengthy Testing, FDA Says
The Food and Drug Administration said this week that vaccine developers would not need to conduct lengthy randomized controlled trials for vaccines that have been adapted to protect against concerning coronavirus variants. From a report: The recommen.....»»
COVID Variants May Arise in People with Compromised Immune Systems
The case history of a U.K. man in his 70s shows how selective “pressures” bring about viral mutations -- Read more on ScientificAmerican.com.....»»